Reverse T3

Reverse T3
Abbreviation	rT3
Molecular formula	C₁₅H₁₁I₃NO₄
Type	Thyroid hormone metabolite (inactive isomer of T3)
Administration	Endogenous only
Bioavailability	N/A
Synonyms	3,3',5'-Triiodothyronine
Source	Peripheral deiodination of Thyroxine (T4) via type III deiodinase
Ray's verdict	Generally hurts Rises under stress, low glucose, high cortisol, and high free fatty acids; tissue thyroid effect falls while lab T4/TSH can still look normal

Reverse T3 (rT3) is an inactive product of thyroxine (T4). Under stress, low glucose, high cortisol, and high free fatty acids, more T4 becomes reverse T3 instead of active triiodothyronine (T3). Tissue thyroid effect falls while labs can still look "normal."

History

Etymology

The name describes its relationship to T3: it is a structural mirror, an isomer with the same three iodine atoms attached at a different position on the thyronine ring, produced instead of active T3 under certain conditions.

Reverse T3 was identified in the 1970s once chromatography methods became sensitive enough to distinguish it from active T3 in blood.

Reverse T3 was established as a distinct, naturally-occurring T4 metabolite in the early 1970s, once chromatographic methods sensitive enough to separate it from T3 became available. It gets its name from having the same three iodine atoms as T3 but attached at the mirror-image (3,3',5') ring positions instead of T3's own (3,5,3') pattern, making it a "reversed" isomer of the active hormone rather than a wholly different molecule.

Structure/Chemical properties

Reverse T3 shares T3's molecular formula (C₁₅H₁₁I₃NO₄) and the same three-iodine count as thyroxine's other deiodination product, but the iodine on the outer (phenolic) ring sits at the 3' position instead of 5'. That shift in iodine placement is enough to abolish activity at the thyroid hormone receptor while still letting rT3 occupy transport and enzyme binding sites meant for T3.

Function/Mechanism of Action

T4 is deiodinated into either active T3 (removal of an iodine from the outer ring, via type I or II deiodinase) or inactive reverse T3 (removal from the inner ring, via type III deiodinase). Which path dominates is not fixed: cortisol, adrenaline, low glucose, and high free fatty acids all shift conversion toward reverse T3 and away from T3. Because reverse T3 competes with T3 for the same deiodinase enzymes and transport proteins without activating the thyroid hormone receptor, elevated rT3 can blunt T3's effects even while total or free T3 measurements look adequate.

A 5-day military ranger training course combining heavy physical exercise with severe caloric restriction showed this shift directly: in 24 young, fit cadets, T3 fell and reverse T3 rose together as the course wore on, while TSH stayed suppressed throughout rather than rising to compensate. The same combination of eating less and exercising more that is often given as generic health advice reproduced a lab pattern indistinguishable from starvation-adapted low thyroid function.

Because the actions of T3 can be inhibited by many factors, including polyunsaturated fatty acids, reverse T3, and excess thyroxine, the absolute level of T3 can't be used by itself for diagnosis.

— Ray Peat

Clinical significance

Reverse T3 is not administered as a drug; it has no approved clinical use and is measured only as a lab marker. A high reverse T3 relative to T3, sometimes called "T3 resistance" informally, is used by some clinicians as evidence that stress, illness, or fasting is diverting thyroid metabolism away from active T3 despite normal-looking TSH and T4. This is not a formally recognized diagnostic category in mainstream endocrinology, which generally treats reverse T3 elevation as a byproduct of illness ("low T3 syndrome" / "sick euthyroid syndrome") rather than a condition to treat directly. A 201-patient ICU cohort found 32.3% had low T3 (below 60 ng/dL) within 48 hours of admission, and those patients had substantially higher in-hospital mortality (24.6% vs. 8.1%), though the association weakened after adjusting for overall illness severity. In the bioenergetic framework, lowering the drivers, eating adequate carbohydrate, reducing polyunsaturated fat intake, and supporting T3 conversion directly, is favored over targeting reverse T3 as an isolated number.

Practice

Lower the drivers: eat carbohydrate, cut seed oils, support thyroid with T3-containing therapy when conversion is poor, and reduce chronic stress load.

Do not chase a single rT3 number without pulse, temperature, and symptoms. See Triiodothyronine, Thyroxine, NDT, Hypothyroidism, Basal temperature.

See also

• Triiodothyronine
• Thyroxine
• Thyroid
• Stress
• PUFA